UNSPSC 51124104: Adenosine triphosphate

This classification denotes a nucleotide with the molecular formula C10H16N5O13P3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8L70Q75FXE. European Medicines Agency schedules adenosine triphosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12741MIG. The term adenosine triphosphate is an International Nomenclature of Cosmetic Ingredients designation. Most nations, for tariff and trade purposes, schedule adenosine triphosphate under HS 29349990 and SITC 51579.

As of Q4 2014, ADENOSINE TRIPHOSPHATE remains US FDA's Preferred Term for this commodity. Adenosine triphosphate bears US NLM identifiers UMLS ID C0001480 and NCI Concept Code C209. SMILES: C1NC(C2C(N1)N(CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N.

UNSPSC 51124104 Adenosine triphosphate, a Commodity code, encompasses emergency medications and pharmaceutical products that state and local governments—particularly fire rescue departments, health agencies, and cooperative purchasing organizations—procure for emergency medical services, hospital systems, and public health programs. Recent solicitations show state and local buyers purchasing adenosine and related advanced life support medications (epinephrine, labetalol, diltiazem) in vial and injectable forms, with strict expiration-date and shelf-life requirements, cold-chain compliance where applicable, and OSHA Safety Data Sheet documentation. The issuing bodies include municipal fire departments (Tampa Fire Rescue through the City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving participating state and local government facilities across multiple states including Oregon). The code sees activity from both direct municipal procurement and cooperative purchasing frameworks that aggregate demand across jurisdictions.

The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue, with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00; the solicitation required 330 units of adenosine 6mg vials among other cardiac medications, with delivery within ten calendar days and a one-year initial term plus renewal options. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather vendor capabilities for a direct-to-manufacturer pharmacy program, signaling longer-term strategic procurement planning. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through MMCAP in January 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, serving participating state and local facilities across Oregon and Minnesota; the RFP required vendors to meet cGMP and Drug Supply Chain Security Act compliance, maintain relationships with authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), and achieve product availability by July 1, 2026. Activity concentrates in Florida, Texas, and the upper Midwest, with cooperative purchasing structures increasingly prevalent for pharmaceutical procurement.